Pranav Abraham, PhD
About Pranav Abraham, PhD
Pranav Abraham, PhD, is the Lead of Global Health Economics Outcomes Research for Rare Hematology & Oncology at Bristol Myers Squibb in Princeton, New Jersey.
Current Role at Bristol Myers Squibb
Pranav Abraham, PhD, currently serves as the Lead of Global Health Economics Outcomes Research, Rare Hematology & Oncology at Bristol Myers Squibb. Based in Princeton, New Jersey, United States, he has been leading this vital sector since August 2017. His role focuses on the economic aspects of healthcare outcomes, particularly within the specialized field of rare hematology and oncology.
Past Experience at Sanofi Genzyme
From 2015 to 2017, Pranav Abraham worked at Sanofi Genzyme in the Global Health Economics and Outcomes Research, Rare Diseases division, based in the Greater Boston Area. Additionally, in 2015, he undertook a PhD Internship at the same company, where he concentrated on patient outcomes and medical economics for multiple sclerosis and rare diseases. This experience provided him with valuable insights into the economic impacts of rare diseases.
Internship at Evidera
In the summer of 2013, Pranav Abraham interned at Evidera, previously part of United BioSource Corporation, in Bethesda. During this 2-month internship, he focused on health economics modeling and simulations. This role honed his skills in developing and utilizing economic models to predict healthcare outcomes.
Education and Background
Pranav Abraham holds a Doctor of Philosophy (Ph.D.) from the Massachusetts College of Pharmacy and Health Sciences. He also earned a Bachelor of Pharmacy (B.Pharm.) degree from the University of Mumbai. His educational background combines pharmacy and health economics, equipping him with a comprehensive understanding of both clinical and economic aspects of healthcare.
Early Career and Volunteering
In 2012, Pranav Abraham volunteered as an intern at Boston Healthcare Associates in Greater Boston Area. This early exposure to health economics laid the foundation for his future work. Over the years, he has accumulated extensive experience in various aspects of health economics, particularly in modeling, simulations, and outcomes research.